All posts

Autoimmune Nutrition

The Autoimmune Protocol (AIP) Diet: What the Evidence Actually Says

By Swetha RajuSeptember 202511 min readUpdated

The autoimmune protocol (AIP) is a structured elimination diet developed within the paleo community in the early 2010s and now used widely — and often unsupervised — by people with Hashimoto's, IBD, lupus, rheumatoid arthritis, psoriasis, and unexplained 'inflammation.' It removes a long list of foods believed to trigger immune dysregulation in susceptible people, then systematically reintroduces them to identify personal triggers. It is restrictive, polarizing, and surprisingly under-studied. The small body of human evidence we do have is more interesting than most clinicians realize and less conclusive than most influencers claim.

Here is the mechanistic rationale, every published human trial of the protocol, what AIP plausibly does and does not do, who should not try it, and how to run a reintroduction phase that actually earns its restriction.

Overhead flat lay of AIP-friendly foods — grass-fed beef, wild salmon, bone broth, sauerkraut, avocado, roasted sweet potato, leafy greens, olive oil, and fresh herbs on warm linen.
The strict AIP plate: animal protein, seafood, non-nightshade vegetables, fermented foods, and healthy fats — no grains, dairy, eggs, or nightshades.

The mechanistic rationale

AIP rests on three overlapping hypotheses about how the modern Western diet may amplify autoimmune activity in genetically susceptible people. None are settled science; all have mechanistic support in the literature.

Three overlapping hypotheses
  1. Leaky-gut hypothesis

    Certain foods increase intestinal permeability and let incompletely digested proteins interact with mucosal immunity, driving systemic inflammation [1].

  2. Molecular mimicry

    Structural overlap between dietary proteins and self-tissues — for example gliadin and thyroid peroxidase — may amplify autoimmune signaling in susceptible people [2].

  3. Microbiome dysbiosis

    The Western pattern shifts gut communities toward pro-inflammatory species, and dysbiosis is now consistently observed in IBD, RA, and lupus [3].

AIP operationalizes all three by removing the most-cited dietary suspects: gluten, dairy, eggs, nightshades, legumes, nuts, seeds, sugar, alcohol, seed oils, additives, and coffee.

What AIP eliminates and what it emphasizes

EliminatedEmphasized
Grains (all, including rice, oats, corn)Vegetables (non-nightshade)
Legumes (beans, lentils, peanuts, soy)Fruit in moderation (berries preferred)
Dairy (all)High-quality animal protein, including organ meats
EggsFatty fish and seafood (≥3×/wk)
Nuts and seedsBone broth (collagen, glycine)
Nightshades (tomato, potato, pepper, eggplant)Fermented foods (sauerkraut, kombucha)
Refined sugar, honey limitedOlive oil, avocado, coconut oil
Alcohol, coffeeHerbs (most), green/herbal tea
Processed seed oils (soy, corn, canola)Sea salt, gelatin
Food additives (emulsifiers, gums, dyes)Spices excluding nightshade-derived
The standard AIP elimination list. Some 'modified AIP' variants reintroduce nuts, seeds, eggs, and nightshades earlier; others stay strict for 6–12 weeks.

What the human research actually shows

TrialCondition (n)ProtocolOutcome
Konijeti 2017 [4]IBD (15)6 wk transition + 5 wk maintenance73% clinical remission by wk 6; mucosal improvement on endoscopy
Abbott 2019 [5]Hashimoto's (16 women)10 wk AIP + lifestyle↑ QoL, ↓ hs-CRP; no change in thyroid antibodies in 10 wk
Chandrasekaran 2019 [6]Crohn's (9, open-label)11 wk↓ fecal calprotectin; clinical improvement
Konijeti 2024 (in progress)IBDRCT (ongoing)Awaited
Every published trial of the formal AIP protocol in adults. Note the small sample sizes, the absence of randomization in most, and the short duration. This is an early evidence base.

What the data supports: AIP appears feasible for motivated patients, can produce meaningful symptom improvement in IBD over 6–12 weeks, can improve QoL and lower hs-CRP in Hashimoto's, and is associated with reductions in inflammatory markers across the conditions studied. What the data does not yet support: that AIP outperforms a Mediterranean or whole-food anti-inflammatory pattern [7], that it changes long-term disease trajectory, that it produces sustained antibody reductions in autoimmune thyroid disease, or that it can replace disease-modifying medication in active flares.

How to run a structured AIP trial — if you're going to

The diet only earns its restriction if it is genuinely time-limited and followed by a careful reintroduction phase. A protocol that drifts into months of indefinite elimination loses the diagnostic value and adds nutrient-deficiency, social, and disordered-eating risks [8].

The two phases
PHASE 1Elimination30–60 days · strict listBaseline symptom journalPHASE 2ReintroductionOne food · 3 days · watch 72hPersonalized maintenance dietSkip Phase 2 and you get the restriction without the answer.
AIP isn't a diet — it's a two-phase experiment. The restriction only pays off if you complete the reintroduction.
Phase 1 · Elimination (30–60 days)
  1. Pick a window

    Most clinicians use 30 days minimum. IBD trials used 6 weeks; the Hashimoto's trial used 10.

  2. Plan the menu first

    Rotate 8–10 recipes you actually enjoy. Novelty burnout is the #1 reason people quit.

  3. Eat enough

    Front-load calories and protein. Under-eating drives the 'I feel worse on AIP' complaint.

  4. Hydrate + electrolytes

    Sodium losses are common. Add a pinch of salt to meals; sip electrolytes if energy dips or headaches show up.

  5. Symptom journal

    Daily 0–10 scales for fatigue, joint pain, GI, mood, and sleep. Memory will lie to you here.

Restrictive diets fail on novelty and under-eating, not on willpower. Front-load calories, rotate 8–10 recipes you actually enjoy, and journal daily.
Phase 2 · Reintroduction (the diagnostic phase)
  1. Start with low-risk foods

    Egg yolks, ghee, seed-based spices, and nuts are the usual first reintroductions.

  2. Three days, three portions

    Day 1: small portion. Day 2: normal portion. Day 3: larger portion. Then wait 72 hours symptom-free before the next food.

  3. Know the reaction window

    GI symptoms in hours; joint or skin symptoms in 24–72 hours; mood and fatigue often within a day.

  4. Pull and retry

    A reaction warrants pulling that food and re-trying in 4–8 weeks. Persistent reaction = genuine intolerance.

  5. Land on a maintenance diet

    Most people add back 70–90% of eliminated foods. That personalized 'no' list is the goal — not lifelong restriction.

This is where the work pays off — and the phase most people skip. Do it methodically or the whole experiment is wasted.

Where AIP can go wrong

  • Long-term restriction without reintroduction

    Risks nutrient gaps — calcium (no dairy), fiber (no legumes/grains), iodine (no iodized salt or dairy), B vitamins (no fortified grains) — and a strained relationship with food [8].

  • Dropping fiber and losing microbial diversity

    Removing legumes and whole grains lowers fiber intake and reduces microbial diversity unless replaced aggressively by vegetables and fermented foods [3].

  • Running it in the wrong life stage

    Not appropriate during pregnancy (unproven safety, increased nutrient needs), in eating-disorder history (restriction triggers relapse), or in significant kidney disease without supervision (high protein and oxalate loads).

  • Underestimating the cost + time burden

    Animal-protein and produce-heavy eating is not cheap, and phase 1 requires near-total home cooking.

  • Letting it become identity

    Patients sometimes stay on it indefinitely despite no clear benefit, missing other interventions that would help more.

Who should not try AIP without supervision

Match yourself to the closest card. If any apply, work with a rheumatologist, gastroenterologist, or specialist dietitian before starting — not after something goes wrong.

Eating disorder history

Any restrictive-eating history — anorexia, orthorexia, ARFID — makes an elimination diet high-risk for relapse. AIP's rigid rules can look like recovery but function like relapse. This is a hard no without an eating-disorder-informed clinician on board.

Pregnancy or breastfeeding

Nutrient needs are higher, and safety data for AIP in these windows is essentially nonexistent. Continue an anti-inflammatory whole-food pattern instead — don't start a new elimination protocol.

Type 1 diabetes

Cutting entire carb groups shifts insulin needs day-to-day and raises hypoglycemia risk. If you and your endocrinologist agree it's worth trying, tighten CGM review and be ready to adjust basal and bolus doses at every phase transition.

Advanced CKD or transplant

The high animal-protein, high-oxalate emphasis (bone broth, leafy greens, nuts on reintroduction) can worsen phosphorus, acid load, and oxalate exposure. Get a renal dietitian to individualize — a standard AIP list is not renal-safe.

Active flare on biologics

Don't run an experiment during an active flare. Wait until your rheumatology team has you stable, then trial AIP as an adjunct — never as a replacement for disease-modifying therapy.

Tracking reintroductions so the work actually pays off

The elimination phase only earns its restriction if the reintroduction phase is rigorous. Add one food group at a time, watch for 2–3 days, increase to a normal serving, then track symptoms for a full 72 hours before introducing the next food. A simple journal (food, time, symptoms, severity 0–10) makes patterns visible that memory will miss. Many patients are surprised to find that the foods they were most worried about cause no reaction, and that one or two unexpected items (often dairy or nightshades for autoimmune thyroid; gluten or eggs for IBD) are the actual triggers.

How AIP compares to other anti-inflammatory patterns

PatternEvidence baseRestrictionBest fit
MediterraneanLargest (PREDIMED [7], dozens of RCTs)LowFirst-line for almost everyone
DASHStrong for BP, CV, hs-CRPLow–moderateHypertension, CKD, metabolic syndrome
AIPSmall RCTs in IBD, Hashimoto'sVery highTrial when standard patterns fail; diagnostic elimination
Specific Carbohydrate Diet (SCD)Pediatric IBD evidence [9]HighIBD-specific alternative to AIP
Strength of evidence, restriction burden, and best-fit context for the four most common anti-inflammatory dietary approaches.

What this is not

AIP is not a validated treatment for cancer, thyroid replacement, or active flares requiring immunosuppression — it's an adjunct that may reduce symptom burden and identify individual triggers. Stay on disease-modifying medication unless your specialist directs otherwise. The mechanistic story is interesting, the small trials are encouraging, and the diagnostic value of a structured elimination can be real — but it is not a cure, not a forever diet, and not a substitute for the standard of care for your specific condition.

References

  1. 1.Fasano A. Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiol Rev 2011;91(1):151–175. Read source ↗
  2. 2.Cusick MF, Libbey JE, Fujinami RS. Molecular mimicry as a mechanism of autoimmune disease. Clin Rev Allergy Immunol 2012;42(1):102–111. Read source ↗
  3. 3.Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell 2014;157(1):121–141. Read source ↗
  4. 4.Konijeti GG, et al. Efficacy of the autoimmune protocol diet for inflammatory bowel disease. Inflamm Bowel Dis 2017;23(11):2054–2060. Read source ↗
  5. 5.Abbott RD, et al. Efficacy of the autoimmune protocol diet as part of a multidisciplinary, supported lifestyle intervention for Hashimoto's thyroiditis. Cureus 2019;11(4):e4556. Read source ↗
  6. 6.Chandrasekaran A, et al. The autoimmune protocol diet modifies intestinal RNA expression in inflammatory bowel disease. Crohn's Colitis 360 2019;1(3):otz016. Read source ↗
  7. 7.Estruch R, et al. Primary Prevention of CVD with a Mediterranean Diet (PREDIMED). NEJM 2018;378:e34. Read source ↗
  8. 8.Hosseini B, et al. Elimination diets in adults: nutritional adequacy and risks. Nutrients 2020;12(11):3474. Read source ↗
  9. 9.Suskind DL, et al. Clinical and fecal microbial changes with the Specific Carbohydrate Diet in pediatric Crohn's disease. J Pediatr Gastroenterol Nutr 2018;66(1):155–160. Read source ↗

About the author

Swetha Raju

Columbia M.S. Candidate in Clinical Human Nutrition · AKF Certified Kidney Health Coach · NKF Medical Advisory Committee (MAC) Member · NKF peer mentor · CKD patient advocate · Published nutrition researcher

Swetha Raju is the founder of NephroNourish. As a published researcher and lifelong chronic disease patient, she translates renal nutrition science into practical guidance people can actually use.

A note on scope. This article is educational and not individual medical advice. Always discuss changes with your nephrologist, dietitian, or care team.